Opthea Ltd (OPT) |
|
9.25 -0.1 (-1.07%)
|
03-07 02:54 |
|
Open: |
9.42 |
Pre. Close: |
9.35 |
|
High:
|
9.421 |
Low:
|
8.98 |
|
Volume:
|
7,581 |
Market Cap:
|
397M |
|
|
|
|
Opthea Limited, a biotechnology company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3 for the treatment of wet age-related macular degeneration and diabetic macular edema. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
9.44 - 9.497 |
9.497 - 9.539 |
|
Low:
|
8.848 - 8.921 |
8.921 - 8.976 |
|
Close:
|
9.152 - 9.262 |
9.262 - 9.344 |
|
Technical analysis |
as of: 2021-03-05 5:11:37 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 12.91  One year: 14.41 |
| Support: |
Support1: 8.98 Support2: 7.47 |
| Resistance: |
Resistance1: 11.06 Resistance2: 12.34 |
| Pivot: |
10.45 |
| Moving Average: |
MA(5): 9.67 MA(20): 10.63
MA(100): MA(250): |
| MACD: |
MACD(12,26): -0.56 Signal(9): -0.43 |
| Stochastic oscillator: |
%K(14,3): 17.70 %D(3): 23.83 |
| RSI: |
RSI(14): 32.57 |
| 52-week: |
High: 14.00 Low: 8.98 Change(%): -24.8 |
| Average Vol(K): |
3-Month: 1690 10-Days: 1540 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.OPT has closed above bottom band by 11.5%. Bollinger Bands are 0% narrower than normal. |
|
|
Headline News |
Wed, 24 Feb 2021
Opthea Finalizes Study Designs and Start-up Activities for Phase 3 Pivotal Clinical Trials of OPT-302 in Wet AMD - GlobeNewswire
Tue, 20 Oct 2020
Loss-Making Opthea Limited (ASX:OPT) Expected To Breakeven In The Medium-Term - Yahoo Finance
Fri, 16 Oct 2020
Opthea Announces Pricing of Initial Public Offering in the United States - GlobeNewswire
Tue, 13 Oct 2020
Opthea to raise $160M in IPO - Seeking Alpha
Sun, 11 Oct 2020
Opthea Announces Launch of Proposed Initial Public Offering in the United States - GlobeNewswire
Thu, 10 Sep 2020
Opthea Appoints US-Based Non-Executive Director Australian Stock Exchange:OPT.AX - GlobeNewswire
|
Financial Analysis |
| Growth |
NA |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
NA |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
NA |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Neutral |
Discounted cash flow: |
Neutral |
| Return on Assets: |
Neutral |
Price to Earnings: |
Neutral |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
42 |
| Shares Float (M) |
20 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
7.16 |
|
Shares Short (K)
|
37 |
|
Shares Short P. Month (K)
|
4 |
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-29.0 |
|
Return on Equity (ttm)
|
-34.5 |
|
Qtrly Rev. Growth
|
0.2 |
|
Gross Profit (p.s.)
|
-0.009 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
|
|
Price to Cash Flow
|
|
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
